DiaSorin S.p.A. (DSRLF)
USD 109.01
(0.0%)
USD 109.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 348.22 Million USD | 6.16% |
| 2022 | 328.03 Million USD | -3.17% |
| 2021 | 338.77 Million USD | 44.79% |
| 2020 | 233.98 Million USD | 21.81% |
| 2019 | 192.08 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 327.71 Million EUR | 0.0% |
| 2023 Q4 | 315.5 Million EUR | 0.0% |
| 2023 FY | 348.22 Million USD | 6.16% |
| 2023 Q2 | 351.78 Million USD | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 FY | 328.03 Million USD | -3.17% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q2 | 313.39 Million EUR | 0.0% |
| 2022 Q4 | 328.03 Million USD | 0.0% |
| 2021 Q2 | 202.98 Million EUR | 0.0% |
| 2021 FY | 338.77 Million USD | 44.79% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 298.04 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 Q4 | 191.23 Million EUR | 0.0% |
| 2020 FY | 233.98 Million USD | 21.81% |
| 2020 Q2 | 195.28 Million EUR | 0.0% |
| 2019 FY | 192.08 Million USD | 0.0% |
| 2019 Q4 | 171.12 Million EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 Q2 | 190.73 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q4 | 183.75 Million EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q2 | 182.32 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q4 | 171.32 Million EUR | 0.0% |
| 2017 Q2 | 152.47 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2016 Q2 | 134.54 Million EUR | 10.68% |
| 2016 Q1 | 121.56 Million EUR | 5.4% |
| 2016 Q3 | 141.74 Million EUR | 5.35% |
| 2016 Q4 | 135.63 Million EUR | -4.31% |
| 2015 Q1 | 114.6 Million EUR | -6.56% |
| 2015 Q4 | 115.33 Million EUR | -2.66% |
| 2015 Q3 | 118.47 Million EUR | -0.41% |
| 2015 Q2 | 118.96 Million EUR | 3.81% |
| 2014 Q1 | 122.15 Million EUR | 2.62% |
| 2014 Q2 | 125.53 Million EUR | 2.77% |
| 2014 Q3 | 121.28 Million EUR | -3.38% |
| 2014 Q4 | 122.64 Million EUR | 1.12% |
| 2013 Q2 | 111.84 Million EUR | 1.59% |
| 2013 Q3 | 115.06 Million EUR | 2.88% |
| 2013 Q1 | 110.08 Million EUR | 0.0% |
| 2013 Q4 | 119.03 Million EUR | 3.45% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -91781.259% |
| Arrayit Corporation | 464.19 Thousand USD | -74918.52% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -45901.317% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 14600937.317% |
| DermTech, Inc. | 1 Million USD | -34584.26% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | -10455.267% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | -38195.309% |
| iMD Companies, Inc. | 38.31 Thousand USD | -908736.961% |
| IDenta Corp. | 442.28 Thousand USD | -78635.006% |
| Interpace Biosciences, Inc. | 1.22 Million USD | -28280.601% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -213361.225% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -44317.088% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 92861425.333% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -74185.257% |
| PharmChem, Inc. | 391.93 Thousand USD | -88748.455% |
| Proteome Sciences plc | 1.06 Million USD | -32582.275% |
| Response Genetics, Inc | 133 Thousand USD | -261727.045% |
| Rennova Health, Inc. | 242.64 Thousand USD | -143414.175% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -471136.951% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -364077.294% |
| Todos Medical Ltd. | 1.02 Million USD | -34006.789% |